A recent study of breast cancer patients showed that about a third of women stopped taking their tamoxifen (nolvadex) before the end of the recommended 5 years.
Tamoxifen for premenopausal women, and aromatase inhibitors for postmenopausal women, are hormonal therapies that when given after surgery for breast cancer can dramatically increase a breast cancer patients chance of cure – by as much as 50 percent. They also decrease the chance of getting a second breast cancer. These are pills...


